We can’t show the full text here under this license.
Abstract
Nanotechnology may enhance the delivery and effectiveness of therapies for glioblastoma.
- Glioblastoma is characterized as the most aggressive and lethal primary brain tumor in adults.
- Current treatments provide limited survival benefits due to challenges like the and tumor heterogeneity.
- Nanotechnology offers a platform to improve the delivery and specificity of therapeutic agents.
- Nanoscale systems may help overcome biological and pharmacological barriers in glioblastoma treatment.
- Recent strategies in nanomedicine show promise but face challenges to clinical translation.
Simplified